Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells

Environmental Toxicology and Pharmacology

Volumn 2, Issue 1, 1996, Pages 59-68

  Willets, J M ^a,d   Lambert, D G ^b   Lunec, J ^a   Griffiths, H R ^a   Phillipson, O ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Pharmacology and Therapeutics Group   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Catecholamine; Homeostasis; Mitochondria; Neurotox icity; TMIQ (1,2,3,4 tetrahydro 2 methyl 4,6,7 isoquinolinetriol)

Indexed keywords

ASCORBIC ACID; CLORGYLINE; IMIPRAMINE; LACTATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SELEGILINE; TETRAHYDROISOQUINOLINE DERIVATIVE; TROLOX C;

ANIMAL TISSUE; ARTICLE; CATECHOLAMINE UPTAKE; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER MITOCHONDRION; MITOCHONDRIAL RESPIRATION; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030586825     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/1382-6689(96)00030-0     Document Type: Article

References (48)

1. 3H]noradrenaline in cultured neuronal cells. Br. J. Anaesth. 71, 540.
2. 3H]noradrenaline from SH-SY5Y human neuroblastoma cells. Br. J. Anaesth. 72, 98.
3. 2- and cyclic AMP, Br. J. Pharmacol. 111, 787.
4. Axelrod J., 1966, Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines, Pharmacol. Rev. 18, 95.
5. Basma A.N., E.J. Morris, W.J. Nicklas and H.M. Geller, 1995, L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation, J. Neurochem. 64, 825.
6. Bates H.A., 1981, Pictet-Spengler reactions of epinepherine with formaldehyde and acetaldehyde, J. Org. Chem. 46, 4931.
7. Bohme E., H. Graf and G. Schultz, 1978, Effects of sodium nitroprusside and other muscle relaxants on cyclic GMP formation in smooth muscle and platelets, Adv. Cyclic Nucleotide Res. 9, 131.
8. +, Neurosci. Lett. 100, 306.
9. + antiporters, Arch. Biochem. Biophys. 264, 417.
10. Buckman T., 1991, Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monoamine oxidase, Mol. Chem. Neuropathol. 15, 87.
11. Casado M., A. Bendahan, F. Zafra, N.C. Danbolt, C. Aragon, C. Gimenez and B.I. Kanner, 1993, Phosphorylation and modulation of brain glutamate transporters by protein kinase C, J. Biol. Chem. 268, 27313.
12. Chen L. and L.-Y.M. Huang, 1991, Sustained potentiation of NMDA receptor-mediated glutamate responses by activation of protein kinase C by a μ opioid, Neuron 7, 319.
13. 50) of an enzymatic reaction, Biochem. Pharmacol. 22, 3099.
14. Chiba K., L.A. Peterson, K.P. Castagnoli, A.J. Trevor and N. Castagnoli Jr., 1985, Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Drug Metab. Dispos. 13, 342.
15. Cleeter M.W.J., J.M. Cooper and A.H.V. Schapira, 1992, Irreversible inhibition of mitochondrial Complex I by 1-methyl-4-phenyl-pyridinium: evidence for free radical involvement, J. Neurochem. 58, 786.
16. + in PC12 cells: insights into potential neurotoxicants in Parkinson's disease, J. Neurochem. 62, 1503.
17. 2+ ], and its role in the hormonal regulation of mitochondrial matrix volume. Biochem. J. 258, 817.
18. Davis, P.D., C.H. Hill, E. Keech, G. Lawton, J.S. Nixon, A.D. Sedgwick, J. Wadsworth, D. Westmacott and S.E. Wilkinson, 1989, Potent selective inhibitors of protein kinase C, FEBS Lett. 259, 61.
19. Deitrich R. and V. Erwin, 1980, Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines), Ann. Rev. Pharmacol. Toxicol. 20, 55.
20. Javitch J.A., R.J. D'Amanto, S.M. Strittmatter and S.H. Snyder, 1985, Parkinsonian-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurones explains selective toxicity, Proc. Natl. Acad. Sci. USA 82, 2173.
21. Kohno O., S. Oata and M. Hirobe, 1986, Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in the rat brain, Biochem. Biophys. Res. Commun. 140, 448.
22. + ): identification of a metabolite of MPTP. a selective toxin to the substantia nigra, Neurosci. Lett. 48, 87.
23. Liptrot J., D. Holdup and O. Phillipson, 1993, 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in the rat brain. J. Neurochem. 61, 2199.
24. Liptrot J., D. Holdup and O. Phillipson, 1994, 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes, J. Neural Trans. 96, 51.
25. Morgan A.J., K.J. Murray and R.A.J. Challis, 1993, Comparison of isobutylmethylxanthine and phosphodiesterase-selective inhibitors on cAMP levels in SH-SY5Y neuroblastoma cells, Biochem. Pharmacol. 45, 2373.
26. Murad F., C.K. Mittal, W.P. Arnold, S. Katsuki and H. Kimura, 1978, Guanylate cyclase activation by azide nitrocompounds, nitric oxide, and hydroxyl radical and inhibition by haemoglobin and myoglobin, Adv. Cyclic Nucleotide Res. 9, 145.
27. Naoi M., S. Matsuura, H. Parvez, T. Takahashi, Y. Hirata, M. Minami and T. Nagatsu, 1989a, Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into N-methyl-isoquinolinium ion by monoamine oxidase, J. Neurochem. 52, 653.
28. Naoi M., S. Matsuura, T. Takahashi and T. Nagatsu, 1989b, A N-methyl-transferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion, Biochem. Biophys. Res. Commun. 161, 1231.
29. Naoi M., T. Takahashi, H. Parvez, R. Kayeba, E. Taguchi, K. Yamaguchi, Y. Hirata, M. Minami and T. Nagatsu, 1989c, N-methylisoquinolinium ion as an inhibitor of tyrosine hydroxylase, L-amino acid decarboxylase and monoamine oxidase, Neurochem. Int. 15, 315.
30. Natagsu T. and M. Yashia, 1988, An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostratal region, Neurosci. Lett. 87, 178.
31. Nicklas W.J., I. Vyas and R.E. Heikkila, 1985, Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Life Sci. 36, 2503.
32. Niwa T., N. Takeda, M. Kaneda, Y. Hashizume and T. Nagatsu, 1987, Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian brains. Biochem. Biophys. Res. Commun. 144, 1084.
33. Ohta S., O. Kohno, M. Makino, O. Tackikawa and M. Hirobe M. 1987, Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8, 453.
34. Pai K.S. and Y. Ravindranath, 1991, Protection and potentiation of MPTP-induced toxicity by cytochrome P450 inhibitors and inducer: in vitro studies with brain slices. Brain Res. 555, 239.
35. Plummer C.J., I.C. Kilpatrick, M.W. Jones, B. Goodwin and O.T. Phillipson, 1988, Preliminary identification of N-methyladrenaline in rat retina and brain with HPLC techniques. Eur. J. Pharmacol. 148, 481.
36. 3H]noradrenaline from SH-SY5Y cells, J. Neurochem. 64, 1175.
37. Ramsay R.R. and T.P. Singer, 1986, Energy dependent uptake of N-methyl-4-phenylpyridinium, the toxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria, J. Biol. Chem. 261, 7585.
38. +, Biochem. Biophys. Res. Commun. 134, 743.
39. Ramsay R.R., K.A. McKeown, E.A. Johnson, R.G. Booth and T.P. Singer, 1987, Inhibition of NADH oxidation by pyridine derivatives, Biochem. Biophys. Res. Commun. 146, 53.
40. Ross R.A. and J.L. Biedler, 1985, Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro, Cancer Res. 45, 1628.
41. Sanchez-Ramos J.R., P. Michel, W.J. Weiner and F. Hefti, 1988, Selective destruction of dopaminergic neurones from fetal rat mesencephalon by 1-methyl-4-phenyl-pyridinium: cytochemical and morphological evidence, J. Neurochem. 50, 1934.
42. Saporito M.S., R.E. Heikkila, S.K. Youngster, W.J. Nicklas and H.M. Geller, 1992, Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration, J. Pharmacol. Exp. Therap. 260, 1400.
43. Sayre L.M., F. Wang, P.K. Arora, N.J. Riachi, S.I. Harik and C.L. Hoppel, 1991, Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible pyridinium-like substances, J. Neurochem. 57, 2106.
44. Schultz J.B., R.J. Matthews, M.M.K. Muqit, S.E. Browne and M.F. Beal, 1995, Inhibition of neuronal nitric oxide synthesis by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice, J. Neurochem. 64, 936.
45. Spina M.B., S.P. Squinto, J. Miller, R.M. Lindsay and C. Hyman, 1992, Brain-derived neurotrophic factor protects dopaminergic neurones against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system, J. Neurochem. 59, 99.
46. 3H]Nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by kanogenate binding, J. Pharmacol. Exp. Ther. 260, 427.
47. Willets J.M., D.G. Lambert and H.R. Griffiths, 1993, Suitability of B65 and SH-SY5Y neuroblastoma cells as models for 'in vitro' neurotoxicity testing, Biochem. Soc. Trans. 21, 452S.
48. Youngster S.K., W.J. Nicklas, R.E. Heikkila, 1989, Structure-activity of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. 11. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalysed oxidation of MPTP analogs, J. Pharmacol. Exp. Ther. 249, 829.